Pharma & Biotech - Page 17

IAG Cargo has added Kuala Lumpur as an approved Constant Climate station, strengthening its pharmaceutical logistics presence across Southeast Asia. The move brings the total number of approved Constant Climate locations in

Eurofins Scientific (EUFI) is expanding its high-potency active pharmaceutical ingredient manufacturing operations through its Eurofins CDMO Alphora unit based in Mississauga, Canada. The expansion targets both standard and high-potency small molecule development

Sandoz has struck a major deal with China’s Shanghai Henlius Biotechnology, securing commercialisation rights to three biosimilars currently in early development. The Swiss pharmaceutical company will pay up to $100.5 million upfront

AstraZeneca has reported positive phase 3 results from two separate non-small cell lung cancer trials, though the wins have done little to offset a significant setback elsewhere in its pipeline. The British

Sanofi is laying off 229 employees from its acquired Blueprint Medicines business in Massachusetts as part of a post-acquisition integration process. The cuts were detailed in a state Worker Adjustment and Retraining

EyePoint Pharmaceuticals (EYPT) saw its stock collapse by more than 70% on Monday after its drug-device combination Duravyu stumbled in its first of two phase 3 trial readouts this year. The company

Quanovate Tech, Inc. has voluntarily discontinued a series of advertising claims for its Mira Fertility Monitor and Test Wands following a challenge by The Procter & Gamble Company. The challenge was brought

The debate around separating the measles, mumps and rubella vaccine has focused heavily on public health, parental choice, and vaccine policy choices. However, the pharmaceutical industry faces a distinct and urgent question

Fresenius Kabi has pulled a single batch of its biosimilar Tyenne (tocilizumab-aazg) injection in 20 ml vials following the discovery of glass particles in the product. The German-headquartered drugmaker confirmed the recall